PD46: Prostate Cancer: Basic Research & Pathophysiology II

Podium Session Moderator(s)

• 

  James Brooks, MD

  Stanford University
• 

  Christopher Evans, MD

  Professor and Chair, Department of Urologic Surgery
  University of California, Davis
• 

  Bal Lokeshwar, PHD, MSC

  Professor
  Medical College of Georgia at Augusta University

Presentations:

• 1:00 PM – 1:10 PM

  PD46-01: The expression of androgen receptor splice variant 7 at radical prostatectomy predicts the risk of progression in untreated non-metastatic prostate cancer patients
  

  Podium Presenter: Martina Maggi, MD
• 1:10 PM – 1:20 PM

  PD46-02: Optical Genome Mapping Identifies Clinically Relevant Genomic Rearrangements in Prostate Cancer Biopsy Sample
  

  Podium Presenter: Hyunho Han, MD – Yonsei University College of Medicine
• 1:20 PM – 1:30 PM

  PD46-03: Metastasis prone genes in prostate cancer revealed by targeted sequencing
  

  Podium Presenter: Seunghwan Jeong, MD – Seoul National University Hospital
• 1:30 PM – 1:40 PM

  PD46-04: BRCA1/2 and ATM mutated metastatic prostate cancers may present with low serum PSA
  

  Podium Presenter: Hyunho Han, MD – Yonsei University College of Medicine
• 1:40 PM – 1:50 PM

  PD46-05: Novel Cyclin-Dependent Kinase 12 (CDK12) and Protein Kinase D1 (PrKD1) Interaction in Castration Resistant Prostate Cancer Cell Lines
  

  Podium Presenter: Victor Chalfant
• 1:50 PM – 2:00 PM

  PD46-06: Symptomatic Benign Prostatic Hyperplasia with Immune-Enriched Landscapes Show Lower Incidence of Prostate Cancer Development
  

  Podium Presenter: Nimrod Barashi Gozal, MD
• 2:00 PM – 2:10 PM

  PD46-07: The Role of B7-H4/AR Mediated Immune Escape in Castration Resistance of Prostate Cancer
  

  Podium Presenter: Bintao Hu
• 2:10 PM – 2:20 PM

  PD46-08: Combined treatment with ultrasound and immune checkpoint inhibitors for prostate cancer
  

  Podium Presenter: Fuuka Hayashi
• 2:20 PM – 2:30 PM

  PD46-09: Lipopolysaccharide from dysbiotic gut microbiota promotes inflammatory prostate cancer growth through histamine H1 receptor signaling
  

  Podium Presenter: Makoto Matsushita
• 2:30 PM – 2:40 PM

  PD46-10: Saturated fatty acid promotes prostate cancer development with tumor infiltrating regulatory T cell alteration in a Pten-deficient mouse model
  

  Podium Presenter: Hiromi Sato
• 2:40 PM – 2:50 PM

  PD46-11: Immune Transcriptomic Repertoire Evaluation in Prostate Cancer Progression
  

  Podium Presenter: Derek Van Booven, BS – University of Miami
• 2:50 PM – 3:00 PM

  PD46-12: Preclinical studies using cisplatin/carboplatin to restore the Enzalutamide sensitivity via degrading the androgen receptor splicing variant 7 (ARv7) to further suppress Enzalutamide resistant prostate cancer
  

  Podium Presenter: Yixi Hu